Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Iconic Therapeutics, Inc.
Age
50–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Males or females of any race, ≥50 years of age
Active primary CNV secondary to AMD in the study eye
You may not be if
Any prior treatment of CNV or advanced AMD in the study eye, except for dietary supplements or vitamins
Any intraocular or ocular surface surgery (including cataract surgery and laser procedures) in the study eye within 3 months
Vitrectomy in the study eye
Clareo Health | Open-Label Study of Intravitreal ICON-1 in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)
